New Research Shows Virta Health Cuts Depression by 44% and Anxiety by 30%
New Research Shows Virta Health Cuts Depression by 44% and Anxiety by 30%
Virta presented research at ObesityWeek 2026 showing their AI-powered, individualized nutrition care clears brain fog, eases depression and anxiety, and reduces physical pain
DENVER--(BUSINESS WIRE)--New clinical studies from Virta Health, the leader in metabolic disease reversal, show how Virta’s individual nutrition therapy and AI-powered, clinical care can drastically improve the health of adults living with obesity. The research abstracts, presented at ObesityWeek 2026, revealed Virta members showed noticeable improvements across mental health, cognitive function, sleep, physical pain, and workplace productivity, with or without the use of GLP-1s.
New Research Shows Virta Cuts Depression by 44% and Anxiety by 30% with or without GLP-1s
Share
Today, poor metabolic health drives up to $4 trillion in annual U.S. healthcare spending1. At the same time, employer and health plan spending on GLP-1 medications has surged up to 200% annually2. Virta’s latest research shows that addressing the root cause of metabolic disease through personalized nutrition and continuous clinical support delivers whole health improvements that help people feel and live better every day, even without GLP-1 therapy.
“This latest research adds to the evidence that Virta significantly improves metabolic health, with or without GLP-1s. Behind our approach is our definitive index on metabolic health, connecting billions of data points from member’s food choices, biomarkers, clinical decisions, and outcomes,” said Kristin Bergethon, Chief Medical Officer at Virta Health. “This foundation powers our care model, helping our clinicians and coaches turn insights into guidance. The goal is better health that people can experience in everyday life, with benefits going beyond weight loss, from better sleep and mental clarity to pain and productivity.”
Key Findings from Virta’s ObesityWeek 2026 Research:
- Easing Depression and Anxiety: After six months on Virta, anxiety and depression improved, with overall anxiety scores dropping by 30%, with overall depression scores falling 44%, whether or not a GLP-1 was used.
- Clearing Brain Fog and Improving Sleep: Within six months, Virta members saw a 12% improvement in cognitive function (including memory, concentration, and mental clarity) and an 8% improvement in sleep disturbance scores.
- Relieving Pain and Boosting Work Productivity: Members reported less physical pain and less unproductive work time after six months, with the reductions in pain associated with the improvements at work.
A Defining Year of Clinical Evidence
A milestone year of published, peer-reviewed research from Virta reveals the whole-body impact of their individualized nutrition therapy and clinician-supervised care. Most recently, Virta announced landmark research published in Cardiology and Therapy which found that Virta’s comprehensive approach was associated with a 56% lower risk of heart attack, stroke, or death.
Virta’s published outcomes across five medical journals this year alone, span multiple high-cost, chronic conditions, including:
- Kidneys: Virta participants had a 36% lower risk of a new chronic kidney disease diagnosis and a 62% lower risk of reaching stage 4 disease
- Liver: Virta members experienced 45% to 75% lower rates of serious liver disease and complications
- Stage IV Pancreatic Cancer: Virta’s nutrition-based care extends survival by 34% when paired alongside chemotherapy
- Inflammation: 19 of 21 inflammatory and immune markers declined after one year of Virta care, with improvements largely sustained at two years
To learn more about Virta’s clinical research and outcomes, visit www.virtahealth.com/research.
About Virta Health
Virta Health is the leader in reversing metabolic disease. Through its AI-powered platform, Virta combines personalized nutrition, GLP-1 optimization, and clinical support to deliver metabolic care at scale. Virta partners with the nation’s largest employers, payers, and pharmacy benefit managers to help members live longer, healthier lives, while reducing or eliminating the need for medications. Headquartered in Denver, Colorado, Virta is on a mission to reverse metabolic disease in one billion people. For more information, visit www.virtahealth.com.
1 https://www.cdc.gov/chronic-disease/data-research/facts-stats/index.html
2 GLP-1s Now ‘Predominant Driver’ of Drug Spend Growth, SHRM, April 8, 2025, https://www.shrm.org/topics-tools/news/benefits-compensation/glp1-driving-historic-drug-spend-growth
Contacts
Media Contact
press@virtahealth.com
